Using vaccine responses to plumb the immunologic consequences of tumor necrosis factor blockade with etanercept.
Scheifele
David W
DW
D018501:Antirheumatic Agents / Q000276:immunology / Q000494:pharmacology; D000068800:Etanercept; D006801:Humans; D007109:Immunity / Q000187:drug effects*; D007074:Immunoglobulin G / Q000276:immunology / Q000494:pharmacology*; D007155:Immunologic Factors / Q000276:immunology / Q000494:pharmacology*; D022242:Pneumococcal Vaccines / Q000276:immunology; D018124:Receptors, Tumor Necrosis Factor / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014612:Vaccines / Q000276:immunology*
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D007155:Immunologic Factors; D022242:Pneumococcal Vaccines; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D014612:Vaccines; D000068800:Etanercept